Canada slams Eli Lilly’s patent practices in lawsuit response


The Canadian government has given a scathing assessment of Eli Lilly’s patenting practices in its formal response to the pharmaceutical company’s CAD $500 million ($401 million) lawsuit against it.

Eli Lilly, Canadian government, NAFTA, promise of utility, Special 301 report, patent